NCT07106450

Brief Summary

This study examines how muscle cells communicate with fat cells through tiny packages called extracellular vesicles (EV) during exercise. These vesicles carry important molecules that may affect how the body processes sugar and fat. The research team observed significant variability in the adipose response to exercise, and used this variability to gain further insight into the mechanism through which mature microRNA-1 (miR-1) changes in adipose tissue. The investigators selected six subjects with the highest increase in miR-1 abundance in adipose tissue after exercise and compared them with the six subjects that had the most dramatic decrease in miR-1 abundance after exercise. The research team observed that participants intrinsically vary in their ability to endocytose EV into adipose tissue. It is unclear whether this variance in receptivity is a cause or consequence of the significant difference in EV-delivery of miR-1 to adipose tissue.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 6, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

March 23, 2026

Status Verified

December 1, 2025

Enrollment Period

2.3 years

First QC Date

July 22, 2025

Last Update Submit

March 18, 2026

Conditions

Keywords

muscleextracellular vesiclesadipose

Outcome Measures

Primary Outcomes (2)

  • miR-1 abundance in adipose tissue

    Quantification of mature microRNA-1 levels in subcutaneous adipose tissue biopsies using quantitative Real Time-PCR as validated biomarker of in vivo extracellular vesicle uptake

    60 minutes post-exercise (single measurement)

  • Extracellular vesicle uptake capacity in primary adipocytes

    Measurement of fluorescently-labeled extracellular vesicle internalization in cultured primary adipocytes using confocal microscopy to quantify uptake rates in units of vesicles per minute per cell.

    24-48 hours post-isolation (in vitro culture)

Secondary Outcomes (4)

  • Serum extracellular vesicle miR-1 content

    Baseline, 0, 30, 60, and 90 minutes post-exercise

  • Adipose tissue transcriptomic signatures

    60 minutes post-exercise (single measurement)

  • Adrenergic receptor gene expression in adipose tissue

    60 minutes post-exercise (single measurement)

  • Primary muscle miR-1 transcript levels

    60 minutes post-exercise (single measurement)

Other Outcomes (3)

  • Extracellular vesicle tetraspanin marker profiles using ExoView platform

    Baseline and 90 minutes post-exercise

  • Circulating extracellular vesicle count using ExoView single vesicle analysis platform

    Baseline and 90 minutes post-exercise

  • Extracellular vesicle size distribution using ExoView single vesicle analysis

    Baseline and 90 minutes post-exercise

Study Arms (1)

Acute Resistance Exercise

EXPERIMENTAL

Participants will perform four exercises: squat, knee extension, leg press, and lat pulldown at 80% of 1-RM (repetition maximum) determined during a previous visit.

Behavioral: Acute Resistance Exercise

Interventions

Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).

Also known as: Strength Training
Acute Resistance Exercise

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 30-55 years
  • Sedentary lifestyle (exercise \<1 day/week for at least 3 months prior to enrollment)
  • Able to provide informed consent
  • For Control Group: BMI \< 27 kg/m², normal glucose tolerance, no more than 1 feature of metabolic syndrome
  • For Prediabetic Group: BMI \> 30 kg/m², at least 3 features of metabolic syndrome including prediabetes (defined as fasting plasma glucose 100-125 mg/dL OR 2-hour post-load glucose on 75g OGTT 140-199 mg/dL OR HbA1C 5.7-6.4%)

You may not qualify if:

  • Pregnancy (confirmed by pregnancy test in women of childbearing potential)
  • Type 2 diabetes mellitus
  • Cardiovascular contraindications to resistance exercise
  • Medical conditions that would interfere with muscle or adipose tissue biopsy procedures
  • Use of medications that significantly affect glucose metabolism or exercise response
  • Active participation in structured exercise programs (\>1 day/week) within 3 months of enrollment
  • Inability to safely participate in resistance exercise protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

Prediabetic State

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Yuan Wen, MD, PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuan Wen, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 22, 2025

First Posted

August 6, 2025

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

March 23, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to protect participant privacy and confidentiality. Summary results and findings will be made available through peer-reviewed publications and presentation at scientific conferences.

Locations